Melanoma: open trials in Sweden

• NCT05033678

  Implementation of Teledermoscopy and Artificial Intelligence

  Research · Region Skane

  Department of dermatology, Skane University Hospital, Lund

  Registry updated 2026-10-16

• NCT06697301

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  Trial Treatment · Phase 2/3 · Eikon Therapeutics

  Region Gaevleborg, Gavle · Karolinska University Hospital, Solna

  Registry updated 2026-10-06

• NCT05727904

  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.

  Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg

  Registry updated 2026-09-24

• NCT04752826

  BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  Trial Treatment · Phase 1/2 · BioInvent International AB

  Sahlgrenska University Hospital, Gothenburg · Skånes University Hospital, Lund · Karolinska University Hospital, Solna, Stockholm

  Registry updated 2026-09-18

• 2024-519593-39-00

  SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melanoma

  Trial Treatment · Phase 3 · Karolinska University Hospital

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Region Oerebro Laen, Orebro · Karolinska University Hospital, Solna · Region Vaesterbotten, Umea

  Registry updated 2026-09-10

• NCT07349303

  Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

  Trial Treatment · Phase 2 · Vastra Gotaland Region

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg

  Registry updated 2026-08-26

• 2026-526821-16-00

  Melanoma-TBK1-inhibitor enhanced Immuno Therapy with Checkpoint Inhibitors: a Phase IB/II Trial in Unresectable Stage III or Stage IV Cutaneous Melanoma

  Trial Treatment · Phase 1/2 · Karolinska University Hospital

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Uppsala University Hospital, Uppsala

  Registry updated 2026-07-28

• NCT02332668

  A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Region Skane Skanes Universitetssjukhus, Lund

  Registry updated 2026-07-06

• NCT06246149

  Adjuvant Tebentafusp in High Risk Ocular Melanoma

  Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg

  Registry updated 2026-06-30

• 2023-508156-20-00

  A Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared to Ipilimumab and Nivolumab Only in Patients with Uveal Melanoma Liver Metastases – the SCANDIUM III trial.

  Trial Treatment · Phase 3 · Vaestra Goetalandsregionen

  Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg · Linkoping University Hospital Region Ostergotland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Norrlands University Hospital, Umeå · Uppsala University Hospital, Uppsala

  Registry updated 2026-04-27

• NCT06488482

  Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

  Trial Treatment · Phase 3 · Uppsala University

  Malarsjukhuset Eskilstuna, Eskilstuna · Region Dalarna, Falun · Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg · Region Joenkoepings Laen, Jonkoping · Laenssjukhuset I Kalmar Region Kalmar Laen, Kalmar · Region Vaermland, Karlstad · Linkoping University Hospital Region Ostergotland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Region Oerebro Laen, Orebro · Karolinska University Hospital, Stockholm · Region Vaesternorrland, Sundsvall · Region Vaesterbotten, Umea · Uppsala University Hospital, Uppsala · Region Vaestmanland, Vasteras · Region Kronoberg, Vaxjo

  Registry updated 2026-03-09

• NCT06112314

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  Trial Treatment · Phase 3 · Immunocore Ltd

  Sahlgrenska Akademin - Institutionen for Kliniska Vetenskaper (Institute of Clinical Sciences), Gothenburg · Lanssjukhuset Ryhov Onkologiska kliniken, Jönköping · Skanes Universitetssjukhus - Lund - Onkologiska Klinik, Lund · Karolinska Universitetssjukhuset, Stockholm · Uppsala Universitet - Akademiska Sjukhuset (Uppsala University Hospital), Uppsala

  Registry updated 2026-02-25

• NCT03567889

  Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  Trial Treatment · Phase 3 · Philogen S.p.A.

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg

  Registry updated 2025-12-17

• NCT06794775

  SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

  Trial Treatment · Phase 3 · Hildur Helgadottir

  Sahlgrenska University Hospital, Gothenburg · Skåne University Hospital, Lund · Karolinska University Hospital, Stockholm

  Registry updated 2025-12-12

• NCT05502900

  Adjuvant Melatonin for Uveal Melanoma

  Trial Treatment · Phase 3 · Gustav Stalhammar

  St. Erik Eye Hospital, Stockholm

  Registry updated 2025-05-15

• NCT04793737

  Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases

  Trial Treatment · Karolinska University Hospital

  Division of Head-Neck, Lung and Skin cancers, Theme Cancer, Karolinska University Hospital, Stockholm

  Registry updated 2025-03-05

• NCT06363591

  WoW - Single- vs Two-staged Excisions of Thin Melanoma

  Trial Treatment · Vastra Gotaland Region

  Sahlgrenska University Hospital, Gothenburg

  Registry updated 2025-03-05

• 2024-519060-40-00

  A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccination in patients with metastatic melanoma

  Trial Treatment · Phase 1 · Karolinska University Hospital

  Karolinska University Hospital, Solna

  Registry updated 2025-01-23

• NCT03116412

  A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

  Trial Treatment · Uppsala University

  Södra Älvsborgs Sjukhus, Borås · Malarsjukhuset Eskilstuna, Eskilstuna · Falu Lasarett, Falun · Gävle sjukhus, Gävle · Department of Surgery, Sahlgrenska University Hospital, Gothenburg · Helsingborgs lasarett, Helsingborg · Lanssjukhuset Ryhov, Jönköping · Länssjukhuset i Kalmar, Kalmar · Centralsjukhuset i Karlstad, Karlstad · Linkoping University Hospital, Linköping · Skåne University Hospital, Malmö · Örebro University Hospital, Örebro · Skaraborgs sjukhus Skövde, Skövde · Karolinska University Hospital, Stockholm · Länssjukhuset Sundsvall, Sundsvall · Uddevalla sjukhus, Uddevalla · Umeå University Hospital, Umeå · Akademiska sjukhuset, Uppsala · Västmanlands Sjukhus Västerås, Västerås · Visby lasarett, Visby

  Registry updated 2024-12-16

• NCT03860883

  Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  Trial Treatment · Melanoma and Skin Cancer Trials Limited

  Sahlgrenska University Hospital, Gothenburg · Central Hospital Kristianstad, Kristianstad

  Registry updated 2024-11-27

• NCT06519266

  PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases

  Trial Treatment · Phase 3 · Vastra Gotaland Region

  Sahlgrenska University Hospital, Gothenburg · Linkoping University Hospital, Linköping · Skåne University Hospital, Lund · Karolinska University Hospital, Stockholm · Norrland University Hospital, Umeå · Uppsala University Hospital, Uppsala

  Registry updated 2024-11-25

• NCT06240143

  Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma

  Trial Treatment · Phase 1/2 · The Netherlands Cancer Institute

  Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg

  Registry updated 2024-11-14

• 2022-500307-49-00

  AMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study

  Trial Treatment · Phase 3 · St Erik Eye Hospital

  St. Erik Eye Hospital, Stockholm

  Registry updated 2024-06-04

• NCT03685890

  Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

  Trial Treatment · Phase 1/2 · Vastra Gotaland Region

  Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg

  Registry updated 2024-04-25

• NCT05446155

  BioMEL- Diagnostic and Prognostic Factors in Melanoma.

  Research · Region Skane

  Helsingborg hospital, Helsingborg · Kristianstad Hospital, Kristianstad · Lund University Hospital, Lund · Skane University Hospital Malmö, Malmö

  Registry updated 2024-01-23

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error